| Bioactivity | EGFR-IN-102 (compound 6) is an oral active EGFR inhibitor with the IC50 of 2 nM, and can be used for study of non-small-cell lung cancer[1]. |
| CAS | 2781912-10-3 |
| Formula | C37H37F2N7O2S |
| Molar Mass | 681.80 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ram W. Sabnis, et al. Combination of Allosteric and Orthosteric EGFR Inhibitors for Treating Non-Small-Cell Lung Cancer. ACS Med. Chem. Lett. 2024. |
EGFR-IN-102
CAS: 2781912-10-3 F: C37H37F2N7O2S W: 681.80
EGFR-IN-102 (compound 6) is an oral active EGFR inhibitor with the IC50 of 2 nM, and can be used for study of non-small-
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.